First author or presenter 

Poster title 

Presentation type and further details 

Therapeutic Dermatology  

Atopic dermatitis 

M. Augustin 

Long-term safety and efficacy (up to 152 weeks) of nemolizumab in ARCADIA open-label extension study in adolescents and adults with moderate-to-severe atopic dermatitis  

Oral presentation; Thursday, October 1 

10:45-10:55 AM CET 

Hall N​ 

S. Ständer 

Quantifying the impact of itch and skin lesion severity on quality of life in atopic dermatitis: A longitudinal analysis of the ARCADIA trials  

E-poster 

P1626 

Atopic dermatitis & prurigo nodularis  

F. Legat 

Comparative effects of itch, skin lesion severity and nemolizumab on sleep disturbance in atopic dermatitis and prurigo nodularis  

Oral presentation; Thursday, October 1 

11:15-11:25 AM CET​ 

Hall N​ 

M. Augustin 

Long-term safety profile of nemolizumab over 2 years in moderate-to-severe atopic dermatitis and prurigo nodularis: Post-hoc analysis from ARCADIA LTE and OLYMPIA LTE trials  

E-poster 

P1470 

H. Lima 

Real-world demographics, clinical characteristics, and itch burden of patients with atopic dermatitis and prurigo nodularis receiving advanced systemic therapy in Canada using artificial intelligence-extracted data  

E-poster 

P1092 

Prurigo nodularis 

S. Ständer 

Evolution of clinical response with long-term nemolizumab therapy in prurigo nodularis: From symptom relief to improvements in sleep and quality of life  

E-poster 

P1768 

S. Ständer 

Data-driven conceptual disease model of prurigo nodularis using structural equation modelling  

E-poster 

P2341 

Acne 

A. Layton 

Assessing skin quality in patients with acne and acne scars through retrospective image analysis of trifarotene’s effects on redness and color evenness  

E-poster 

P0081 

Dermatological skincare  

Sensitive Skin 

J. Conway 

Temporally optimized antioxidant serums for daytime defence and nighttime repair: A multicenter clinical investigation 

E-poster 

P2356 

N. Zarabian  

Effects of a triple-acid topical formulation on skin hydration and barrier function  

E-poster 

P0953 

M. Farah 

Skin tone and sensitive skin: An artificial intelligence-driven cross-sectional analysis  

E-poster 

P0926 

M. Farah  

Artificial intelligence-driven identification of stress, overscheduling, and younger age as high-risk factors for sensitive skin  

E-poster 

P0924 

N. Zarabian  

A cross-sectional analysis of hidradenitis suppurativa, sensitive skin syndrome, and primary hyperhidrosis as comorbidities  

E-poster 

P0020 

Acne 

R. Tang 

Clinical and psychosocial outcomes of multi‑active hydrocolloid patch in the management of acne pustules  

E-poster 

P0033 

N. Zarabian 

Targeting acne-related inflammation: Synergistic inhibition of IL-1β responses by a lysine-based dendritic polymer and niacinamide in human keratinocytes  

E-poster 

PCC-12 

N. Zarabian 

Dermatology practitioner approaches to post-isotretinoin acne management  

E-poster 

P0023 

Dermatoporosis 

G. Ablon  

Efficacy of an innovative cream on biomarkers for aging in mature, fragile skin  

E-poster 

P0964 

A. Widgerow  

An innovative cream improves signs and symptoms of dermatoporosis in subjects aged 65 and over  

E-poster 

P0959 

Atopic dermatitis 

M. Sachdev 

A gentle cleanser and barrier-restoring moisturiser regimen in mild to-moderate atopic dermatitis: biophysical, clinical, and quality of life evidence from a prospective baseline-controlled study  

E-poster 

P1663